Authors: JAGERSCHMIDT A FLEURY V ANGERLEROY M THOMAS C AGNEL M OBRIEN DP

Citation: A. Jagerschmidt et al., HUMAN THROMBOPOIETIN STRUCTURE-FUNCTION-RELATIONSHIPS - IDENTIFICATION OF FUNCTIONALLY IMPORTANT RESIDUES, Biochemical journal, 333, 1998, pp. 729-734

Authors: LANGER SZ PARTISETI M JAGERSCHMIDT A RENARD S FAURE C AGNEL M OBRIEN D BESNARD F CULOUSCOU JM GRAHAM D

Citation: Sz. Langer et al., ORPHAN RECEPTORS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 44-44

Authors: JAGERSCHMIDT A GUILLAUME N ROQUES BP NOBLE F

Citation: A. Jagerschmidt et al., BINDING-SITES AND TRANSDUCTION PROCESS OF THE CHOLECYSTOKININ, RECEPTOR - INVOLVEMENT OF HIGHLY CONSERVED AROMATIC RESIDUES OF THE TRANSMEMBRANE DOMAINS EVIDENCED BY SITE-DIRECTED MUTAGENESIS, Molecular pharmacology, 53(5), 1998, pp. 878-885

Authors: JAGERSCHMIDT A GUILLAUMEROUSSELET N VIKLAND ML GOUDREAU N MAIGRET B ROQUES BP

Citation: A. Jagerschmidt et al., HIS(381) OF THE RAT CCKB RECEPTOR IS ESSENTIAL FOR CCKB VERSUS CCKA RECEPTOR ANTAGONIST SELECTIVITY, European journal of pharmacology, 296(1), 1996, pp. 97-106

Authors: JAGERSCHMIDT A GUILLAUME N GOUDREAU N MAIGRET B ROQUES BP

Citation: A. Jagerschmidt et al., MUTATION OF ASP(100) IN THE 2ND TRANSMEMBRANE DOMAIN OF THE CHOLECYSTOKININ-B RECEPTOR INCREASES ANTAGONIST BINDING AND REDUCES SIGNAL-TRANSDUCTION, Molecular pharmacology, 48(5), 1995, pp. 783-789

Authors: JAGERSCHMIDT A POPOVICI T ODONOHUE M ROQUES BP

Citation: A. Jagerschmidt et al., IDENTIFICATION AND CHARACTERIZATION OF VARIOUS CHOLECYSTOKININ-B RECEPTOR MESSENGER-RNA FORMS IN RAT-BRAIN TISSUE AND PARTIAL DETERMINATIONOF THE CHOLECYSTOKININ-B RECEPTOR GENE STRUCTURE, Journal of neurochemistry, 63(4), 1994, pp. 1199-1206